Lamotrigine


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1548 CYP2A6 Increases activity PMID:19961160
1586 CYP17A1 Decreases activity PMID:15730543
1588 CYP19A1 Decreases activity PMID:17959350
16333 INS1 Increases expression PMID:38050455
29277 CYP2C11 Increases activity PMID:19961160
3284 HSD3B2 Decreases activity PMID:15730543
3757 KCNH2 Decreases activity PMID:15716081
3972 LHB Decreases expression PMID:38050455
406947 MIR155 Increases expression PMID:29644860
406953 MIR18A Increases expression PMID:29644860
406991 MIR21 Increases expression PMID:29644860
4288 MKI67 Decreases expression PMID:38050455
4843 NOS2 Increases expression PMID:14511393
5243 ABCB1 Decreases activity PMID:18408562
5460 POU5F1 Decreases expression PMID:37505509
54657 UGT1A4 Increases activity PMID:19845433
5468 PPARG Decreases expression PMID:38050455
596 BCL2 Increases expression PMID:18719996
627 BDNF Increases expression PMID:18719996
6326 SCN2A Decreases activity PMID:11212204
6770 STAR Decreases expression PMID:37505509
79727 LIN28A Decreases expression PMID:37505509
883 KYAT1 Increases activity PMID:16765940

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.